For the Inventor, By the Inventor

Enter assignee name

Ballerup, Denmark

Neurosearch A/s

USPTO Granted Patents = 206

CIPO Patents = 12

EPO Patents = 40

Forward Citations = 863

Loading Chart...

Loading Chart...

180 inventors (with patents filed for the assignee):

Dan Peters (107 out of 115 patents)

Gunnar M Olsen (72 out of 72 patents)

Elsebet Østergaard Nielsen (59 out of 65 patents)

4. Lene Teuber (38 out of 44 patents)

5. Palle Christophersen (28 out of 41 patents)

6. Elsebet Ostergaard Nielsen (26 out of 27 patents)

7. Frank Watjen (26 out of 57 patents)

8. Philip K Ahring (23 out of 25 patents)

9. Peter Moldt (23 out of 24 patents)

10. Daniel B Timmermann (22 out of 25 patents)

11. John Paul Redrobe (19 out of 19 patents)

12. Simon Feldbaek Nielsen (16 out of 22 patents)

13. Birgitte Langer Eriksen (16 out of 22 patents)

14. Tino Dyhring Jørgensen (16 out of 16 patents)

15. Bjarne H Dahl (14 out of 14 patents)

Core Competencies:

Potassium Channel Modulators

Monoamine Neurotransmitter Re-Uptake Inhibitors

Diazabicyclic Aryl Derivatives

Cholinergic Receptor Modulators

Nicotinic Acetylcholine Receptors

Purinyl Derivatives

Oxadiazole Derivatives

Anxiety Treatment

Type 2 Diabetes Treatment

Guanidine Derivatives

Aza-Bicyclo Derivatives

Calcium-Activated Potassium Channels

206 patents: Sort by Forward Citations

1. 8415358 - Pyrazine derivatives and their use as potassium channel modulators (2013-04-09),

2. 8410271 - Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2013-04-02),

3. 8372832 - 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use (2013-02-12),

4. 8362024 - Purinyl derivatives and their use as potassium channel modulators (2013-01-29),

5. 8343960 - 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use (2013-01-01),

6. 8288418 - [object Object] (2012-10-16),

7. 8268838 - Substituted purinyl-pyrazole derivatives and their use as potassium channel modulators (2012-09-18),

8. 8263617 - Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2012-09-11),

9. 8263611 - Hydrochloride salt of an azabicyclo[3.2.1]octane derivative (2012-09-11),

10. 8252806 - Potassium channel modulating agents and their medical use (2012-08-28),

11. 8236793 - Diazabicyclic aryl derivatives as cholinergic receptor modulators (2012-08-07),

12. 8222262 - Indazolyl derivatives useful as potassium channel modulating agents (2012-07-17),

13. 8202884 - Treatment of type 2 diabetes (2012-06-19),

14. 8178544 - 2, 3-diamino-quinazolinone derivatives and their medical use (2012-05-15),

15. 8173658 - Diazabicycylic aryl derivatives and their medical use (2012-05-08),

Neurosearch A/S is a Danish biopharmaceutical company that focuses on the research and development of drugs targeting neurological disorders. With a mission to improve the lives of patients suffering from diseases like Parkinson's, ADHD, and schizophrenia, Neurosearch is dedicated to discovering innovative treatment options. Their expertise lies in the discovery and optimization of drug candidates, as well as conducting pre-clinical and clinical development. For more information, visit their official website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

206 Patents

#2 in Ballerup

#19 in Denmark

#3,998 in the World

Ballerup, Denmark

Neurosearch A/s

Forward Citations = 863

180 inventors:

Dan Peters (107 out of 115 patents)

Gunnar M Olsen (72 out of 72 patents)

Elsebet Østergaard Nielsen (59 out of 65 patents)

4. Lene Teuber (38 out of 44 patents)

5. Palle Christophersen (28 out of 41 patents)

Please report any incorrect information to support@idiyas.com

Loading…